LIVN (LivaNova plc) Margin bathi reged

LivaNova PLC (LIVN) is a global provider of cardiac and neurological solutions that scales profits through international patent sales. This chart illustrates the current gross profit margin trend, where the indicator stands at 68.20. Business efficiency depends on VNS therapy prescriptions and surgical volumes. High FDA compliance and surgeon trust in the devices create a significant barrier to entry for new players.
Rincian metrik keuangan lan pasar LivaNova Corp (LIVN)

LivaNova PLC (LIVN) proprietary manufacturing plants for neurostimulators and cardiac equipment, featuring stringent sterility controls, directly determine the product cost structure. The target gross margin trend reflects the profit share after deducting direct production costs, allowing investors to assess operational efficiency and the business's actual ability to generate cash flows amid market turbulence.